• SP600125: JNK Inhibitor Workflows for Apoptosis & Inflammati

  2026-04-24

  SP600125 from APExBIO delivers high selectivity and versatility for dissecting JNK-driven signaling in apoptosis, inflammation, and cytokine modulation. This guide covers bench-proven workflows, advanced troubleshooting, and actionable assay strategies tailored for robust, reproducible research outcomes.

• VE-822 ATR Inhibitor: Protocols and Troubleshooting in PDAC

  2026-04-23

  VE-822 is redefining DNA damage response inhibition by enabling robust, selective sensitization of pancreatic ductal adenocarcinoma (PDAC) cells to chemoradiotherapy. This article details evidence-backed workflows, advanced applications, and troubleshooting tactics to maximize VE-822’s impact in translational cancer research.

• Adipose-Neural Axis Drives Cardiac Arrhythmia via NPY Signal

  2026-04-23

  Fan et al. (2024) reveal that the interplay between epicardial adipose tissue and the sympathetic nervous system—mediated through leptin and neuropeptide Y (NPY)—is a key driver of cardiac arrhythmias. Their stem cell-based coculture model uncovers novel intervention targets within this adipose-neural axis, with implications for both mechanistic research and therapeutic strategy.

• Sulfo-NHS-SS-Biotin: Precision Cell Surface Protein Labeling

  2026-04-22

  Harness the Sulfo-NHS-SS-Biotin Kit for highly selective, reversible protein and cell surface biotinylation. This guide spotlights optimized protocols, real-world troubleshooting, and how cutting-edge research on glycoRNA–protein domains empowers dynamic interactome discovery.

• QRICH1-Driven ER Stress Promotes HBV-Linked HMGB1 Secretion

  2026-04-22

  This study elucidates how QRICH1, a key effector of endoplasmic reticulum (ER) stress, enhances hepatitis B virus (HBV)-mediated HMGB1 translocation and secretion in hepatocytes. Through in vivo models and clinical specimens, the work uncovers the mechanistic axis linking ER stress, QRICH1, SIRT6 modulation, and HMGB1-driven fibrosis, offering new insights into the pathogenesis of HBV-related liver diseases.

• Proteolytic Neuroligin 1 Fragments Sustain Social Memory via

  2026-04-21

  Liu et al. reveal that the maintenance of social memory relies on social interaction-induced proteolytic processing of Neuroligin 1 in the ventral hippocampus, producing an intracellular fragment (NLG1-CTD) critical for synaptic plasticity and memory persistence. This mechanism integrates extracellular protease activity with downstream signaling, offering new insight into memory maintenance and its disruption in neuropsychiatric disease.

• LY364947: Applied Insights for TGF-β Type I Receptor Kinase

  2026-04-21

  LY364947 empowers researchers with selective, robust inhibition of TGF-β type I receptor kinase, enabling reproducible studies of EMT, fibrosis, and retinal degeneration. This article details optimized workflows, troubleshooting, and novel applications driven by recent advances and validated protocols—positioning LY364947 as an essential preclinical tool.

• Ibrexafungerp vs. Fluconazole-Resistant Candida auris: Effic

  2026-04-20

  Wiederhold et al. demonstrate that ibrexafungerp retains both in vitro and in vivo efficacy against fluconazole-resistant Candida auris, even when the initiation of therapy is delayed. Their strategic use of murine models and comprehensive susceptibility profiling highlight the urgent need for alternative antifungals in the context of rising multidrug resistance.

• Machine Learning Discovers Novel Senolytics for Cell Clearan

  2026-04-20

  This study demonstrates the use of machine learning trained on published data to identify new senolytics—compounds that selectively eliminate senescent cells. The approach drastically reduces screening costs and broadens the chemical space for therapeutic discovery, offering significant implications for cancer and age-related disease research.

• LDN-193189: Selective ALK Inhibitor for BMP Pathway Research

  2026-04-19

  LDN-193189 is a potent, selective ALK inhibitor widely used in BMP signaling pathway research. It effectively blocks Smad1/5/8 phosphorylation and protects epithelial barrier function in vitro and in vivo. APExBIO supplies a rigorously validated form for experimental use.

• Pazopanib Hydrochloride: Precision Assay Interpretation in C

  2026-04-18

  Explore how Pazopanib Hydrochloride (GW786034) enables nuanced interpretation of drug response assays in cancer research. This article uniquely bridges in vitro evaluation insights with practical protocol optimization, revealing new depths for anti-angiogenic agent applications.

• Thapsigargin: SERCA Pump Inhibitor for Advanced Assays

  2026-04-17

  Thapsigargin from APExBIO is a gold-standard SERCA pump inhibitor, uniquely enabling precise manipulation of intracellular calcium signaling and endoplasmic reticulum stress. Its nanomolar potency, fast-acting kinetics, and proven utility in apoptosis assays and neurodegenerative disease models set it apart for translational research.

• Partial BACE Inhibition Reduces Amyloid β Without Synaptic L

  2026-04-16

  Satir et al. (2020) demonstrate that partially reducing amyloid β (Aβ) production via β-secretase (BACE) inhibitors does not impair synaptic transmission in cortical neurons. This finding suggests that moderate BACE inhibition—targeting levels comparable to protective genetic mutations—may offer a safer therapeutic window for Alzheimer's disease intervention.

• Forskolin: Adenylate Cyclase Activator in Stem Cell Assays

  2026-04-15

  Forskolin, a potent adenylate cyclase activator, enables reproducible control of cAMP signaling in stem cell, inflammation, and neuroendocrine workflows. This guide details experimental protocols, troubleshooting, and translational insights for maximizing Forskolin’s impact in bench research and regenerative medicine.

• L-Alanyl-L-Glutamine: Elevating Intestinal Barrier Assays

  2026-04-14

  L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide) transforms gastrointestinal research by combining unmatched stability with targeted mucosal protection. Discover how APExBIO’s B8228 product enables reproducible, robust, and high-sensitivity workflows for barrier function, antioxidant support, and inflammation attenuation.

459 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page